Inhibition of the Ribonuclease H and DNA Polymerase Activities of HIV-1 Reverse Transcriptase by N-(4-tert-Butylbenzoyl)-2-hydroxy-1-naphthaldehyde Hydrazone
The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
HIV-1 reverse transcriptase (RT) is multifunctional, with RNA-dependent DNA polymerase (RDDP), DNA-dependent DNA polymerase (DDDP), and ribonuclease H (RNase H) activities. N-(4-tert-Butylbenzoyl)-2-hydroxy-1-naphthaldehyde hydrazone (BBNH) inhibited both the polymerase and the RNase H activities of HIV-1 RT in vitro. IC50 values for inhibition of RDDP were 0.8-3.4 microM, depending on the template/primer (T/P) used in the assay. The IC50 for DDDP inhibition was about 12 microM, while that for inhibition of RNase H was 3.5 microM. EC50 for inhibition of HIV-1 replication in cord blood mononuclear cells was 1.5 microM. BBNH inhibition of RNase H in vitro was time-dependent, whereas inhibition of RT polymerase activities was immediate. BBNH was a linear mixed-type inhibitor of RT RDDP activity with respect to both T/P and to dNTP, whereas BBNH inhibition of RT RNase H activity was linear competitive. Protection experiments using an azidonevirapine photolabel showed that BBNH binds to the non-nucleoside RT inhibitor (NNRTI) binding pocket. Importantly, the compound inhibited recombinant RT containing mutations associated with high-level resistance to other NNRTI. While BBNH did not inhibit the DNA polymerase activities of other retroviral reverse transcriptases and DNA polymerases, the compound inhibited Escherichia coli RNase HI and the RNase H activity of murine leukemia virus RT. BBNH also inhibited HIV-1 RT RNase H in the presence of high concentrations of other non-nucleoside inhibitors with higher affinities for the NNRTI binding pocket, and of RT in which the NNRTI binding pocket had been irreversibly blocked by the azidonevirapine photolabel. We conclude that BBNH may therefore bind to two sites on HIV-1 RT. One site is the polymerase non-nucleoside inhibitor binding site and the second may be located in the RNase H domain. BBNH is therefore a promising lead compound for the development of multisite inhibitors of HIV-1 RT.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Crystal structure of the ribonuclease H domain of HIV-1 reverse transcriptase
Davies, J. F., Hostomska, Z., Hostomsky, Z., Jordan, S. R., & Matthews, D. A. (1991) · Science · doi:10.1126/science.1707186 · Cited by 570
Research works printed but not linked: 49
- Applegren N., 1995, J. Cellular Biochem., 59, 107, 10.1002/jcb.240590111 · doi:10.1002/jcb.240590111
- Arts E. J., 1994, J. Biol. Chem., 269
- Balzarini J., 1992, J. Biol. Chem., 267, 10.1016/S0021-9258(19)49774-3 · DOI
- Balzarini J., 1994, Proc. Natl. Acad. Sci. U.S.A. 91, 9599−6603
- Cheng Y., 1987, J. Biol. Chem., 262
- Cirino N. M., 1995, Biochemistry 34, 9936−9943
- Cohen K. A., 1991, J. Biol. Chem., 266, 14670, 10.1016/S0021-9258(18)98737-5 · DOI
- Coombs T., 1962, Biochemistry 1, 899−905
- Cushman D., 1977, Biochemistry 25, 5484−5491
- De Vreese K., 1992, Virology 188, 900−904
- Ding J., 1995, Structure 3, 365−379
- Edward J. T., 1988, J. Chem. Eng. Data, 33, 10.1021/je00054a044 · DOI · Paper page
- Engelman A., 1995, J. Virol., 69
- Fletcher R. S., 1995, Biochemistry 34, 4346−4353
- Fletcher R. S., 1995, Biochemistry 34, 10106−10112
- Fletcher R. S., 1996, Protein Expression Purif., 7, 32, 10.1006/prep.1996.0004 · DOI
- Gopalakrishnan V., 1994, J. Biol. Chem., 269
- Gu Z., 1994, J. Biol. Chem., 269
- Hargrave K. D., 1991, J. Med. Chem., 34, 10.1021/jm00111a045 · DOI · Paper page
- Hizi A., 1991, J. Biol. Chem., 266, 10.1016/S0021-9258(18)38108-0 · DOI · Paper page
- Hizi A., 1992, J. Biol. Chem., 267
- Hoffman A. D., 1985, Virology 147, 326−335
- Katayanagi K., 1990, Nature 347, 306−309
- Katayanagi K., 1993, Funct., Genet. 17, 337−346.
- Kohlsteadt L. A., 1992, Science 256, 1783−1790
- Larder B. A., 1989, Science 246, 1155−1157
- Le Grice S. F. J., 1993, A. M., & Goff
- Loya S., 1990, Agents Chemother. 34
- Merluzzi V. J., 1990, Science 250, 1411−1413
- Mizrahi V., 1994, J. Biol. Chem., 269, 10.1016/S0021-9258(17)32159-2 · DOI
- Mohan P., 1994, J. Med. Chem., 37, 10.1021/jm00042a004 · DOI
- Nakamura H., 1991, Nucleic Acids Res. 19
- Palaniappan C., 1995, J. Biol. Chem., 270, 10.1074/jbc.270.9.4861 · DOI · Paper page
- Ren J., 1995, Nat. Struct. Biol. 2, 293−302
- Richman D. D., 1993, Annu. Rev. Pharmacol. Toxicol., 33, 10.1146/annurev.pa.33.040193.001053 · doi:10.1146/annurev.pa.33.040193.001053
- Rodgers D. W., 1995, Proc. Natl. Acad. Sci. U.S.A. 92, 1222−1226
- Schinazi R. F., 1993, Antimicrob. Agents Chemother. 37, 875−881
- Segel I. H., 1975, Enzyme Kinetics. Behavior and Analysis of Rapid-Equilibrium and Steady-State Enzyme Systems
- Silberklang M., 1979, Methods Enzymol., 59, 109
- Smerdon S. J., 1994, Proc. Natl. Acad. Sci. U.S.A. 91, 3911−3915
- South T. L., 1990, Biochemistry 29, 7786−7789
- Starnes M. C., 1989, J. Biol. Chem., 264, 10.1016/S0021-9258(18)83542-6 · DOI · Paper page
- Tan C.-K., 1991, Biochemistry 30, 4831−4835
- Volkmann S., 1993, J. Biol. Chem., 268, 10.1016/S0021-9258(18)53827-8 · DOI · Paper page
- Wu J. C., 1991, Biochemistry 30
- Yang W., 1990, Science 247, 1398−1405
- Yao X.-J., 1992, Virology, 187, 62
- Zhan X., 1994, Biochemistry 33, 1366−1372
- Abbreviations AN, avian myeloblastosis virus
Cited by
Sarafianos, S. G., Marchand, B., Das, K., Himmel, D. M., Parniak, M. A., Hughes, S. H., & Arnold, E. (2009) · Journal of Molecular Biology · doi:10.1016/j.jmb.2008.10.071 · Cited by 535
Self-citationPutting copper into action: copper‐impregnated products with potent biocidal activities
Borkow, G., & Gabbay, J. (2004) · The FASEB Journal · doi:10.1096/fj.04-2029fje · Cited by 366
Self-citationTargeting Metalloenzymes for Therapeutic Intervention
Chen, A. Y., Adamek, R. N., Dick, B. L., Credille, C. V., Morrison, C. N., & Cohen, S. M. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00201 · Cited by 270
RNase H activity: structure, specificity, and function in reverse transcription
Schultz, S. J., & Champoux, J. J. (2008) · Virus Research · doi:10.1016/j.virusres.2007.12.007 · Cited by 150
Menéndez-Arias, L., Sebastián-Martín, A., & Álvarez, M. (2017) · Virus Research · doi:10.1016/j.virusres.2016.12.019 · Cited by 123
HIV-1 ribonuclease H: structure, catalytic mechanism and inhibitors
Beilhartz, G. L., & Götte, M. (2010) · Viruses · doi:10.3390/v2040900 · Cited by 88
“BBNH also failed to inhibit the RNase H activity of HIV-2 RT, which does not possess the NNRTI-binding pocket of HIV-1 RT [96].”
BackgroundCamarasa, M.-J., Velázquez, S., San-Félix, A., Pérez-Pérez, M.-J., & Gago, F. (2006) · Antiviral Research · doi:10.1016/j.antiviral.2006.05.021 · Cited by 66
Active site and allosteric inhibitors of the ribonuclease H activity of HIV reverse transcriptase
Corona, A., Masaoka, T., Tocco, G., Tramontano, E., & Le Grice, S. F. (2013) · Future Medicinal Chemistry · doi:10.4155/fmc.13.178 · Cited by 54
Inhibitors of HIV-1 Reverse Transcriptase—Associated Ribonuclease H Activity
Ilina, T., LaBarge, K., Sarafianos, S. G., Ishima, R., & Parniak, M. A. (2012) · Biology · doi:10.3390/biology1030521 · Cited by 54
Self-citationRetroviral RNase H: structure, mechanism, and inhibition
(2021) · The Enzymes · doi:10.1016/bs.enz.2021.07.007 · Cited by 13
Metadata
- Authors
- Borkow, G., Fletcher, R. S., Barnard, J., Arion, D., Motakis, D., Dmitrienko, G. I., & Parniak, M. A.
- Venue
- Biochemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 1997-03-01
- Volume
- 36
- Issue
- 11
- Pages
- 3179-3185
- ISSN
- 0006-2960 (ISSN-L)
- 1520-4995
- OpenAlex
- W1999889673
- Cited by
- 90
- References
- 1
- FWCI
- 1.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.